Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Astrocytes modulate neuronal development by S100A6 signaling.

Nature communications·2025

Same author

Adverse effects of gestational ω-3 and ω-6 polyunsaturated fatty acid imbalance on the programming of fetal brain development.

Journal of neuroendocrinology·2023

Same author

Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH-018 in male mice.

British journal of pharmacology·2023

Same author

Assay of GTPγS Binding in Autoradiography.

Methods in molecular biology (Clifton, N.J.)·2022

Same author

Physiological Rules of Endocannabinoid Action During Fetal and Neonatal Brain Development.

Cannabis and cannabinoid research·2021

Same author

Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.

International journal of molecular sciences·2021

Search research articles

Related Experiment Video

Updated: May 23, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

Cannabidiol as potential anticancer drug.

Paola Massi¹, Marta Solinas, Valentina Cinquina

¹Department of Pharmacology, Chemotherapy and Toxicology, University of Milan, Milan, Italy.

British Journal of Clinical Pharmacology

|April 18, 2012

Summary

This summary is machine-generated.

Cannabidiol (CBD) shows promise as a non-psychoactive anti-cancer agent. Research suggests CBD can inhibit tumor growth and metastasis, offering a potential alternative to THC for cancer therapy.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Experiment Videos

Last Updated: May 23, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Area of Science:

Oncology
Pharmacology
Molecular Biology

Background:

Cannabinoids, including delta-9-tetrahydrocannabinol (Δ(9)-THC), exhibit anti-tumorigenic properties.
These effects include anti-proliferative, pro-apoptotic, and anti-metastatic actions.
Psychoactive side effects of Δ(9)-THC limit its clinical use, increasing interest in non-psychoactive alternatives like cannabidiol (CBD).

Purpose of the Study:

To review the efficacy of CBD in modulating various stages of tumorigenesis.
To highlight CBD's potential as an alternative therapeutic agent in cancer treatment.
To explore the role of CBD and its analogues in cancer therapy.

Main Methods:

Literature review of studies on cannabinoid effects in cancer.
Analysis of research focusing on CBD's anti-cancer mechanisms.
Examination of preclinical and clinical data regarding CBD's therapeutic potential.

Main Results:

CBD demonstrates anti-proliferative and pro-apoptotic effects in various cancer types.
CBD can interfere with tumor neovascularization, migration, adhesion, invasion, and metastasis.
Evidence supports CBD's efficacy in modulating key steps of tumor development.

Conclusions:

CBD is a promising non-psychoactive cannabinoid with significant anti-tumorigenic potential.
CBD and its analogues warrant further investigation as alternative cancer therapeutics.
Exploring CBD-based therapies could overcome the limitations associated with psychoactive cannabinoids.